59 related articles for article (PubMed ID: 27144826)
21. Mast cell chymase is present in uterine cervical carcinoma and it detaches viable and growing cervical squamous carcinoma cells from substratum in vitro.
Diaconu NC; Rummukainen J; Naukkarinen A; Mättö M; Harvima RJ; Pelkonen J; Harvima IT
Arch Dermatol Res; 2011 Sep; 303(7):499-512. PubMed ID: 21274549
[TBL] [Abstract][Full Text] [Related]
22. [Expression of TLR8 in human cervical cancer HeLa cells and the effect of TLR8 agonist on the cell proliferation and apoptosis].
Yang H; He ZQ; Zhao YX; Wang KW; Zheng D; Su ZL; Tong J; Ma J; Wang SJ; Xu HX
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):643-8. PubMed ID: 22340042
[TBL] [Abstract][Full Text] [Related]
23. Integration of high-risk human papillomavirus DNA is linked to the down-regulation of class I human leukocyte antigens by steroid hormones in cervical tumor cells.
Bartholomew JS; Glenville S; Sarkar S; Burt DJ; Stanley MA; Ruiz-Cabello F; Chengang J; Garrido F; Stern PL
Cancer Res; 1997 Mar; 57(5):937-42. PubMed ID: 9041198
[TBL] [Abstract][Full Text] [Related]
24. A novel curcumin-based vaginal cream Vacurin selectively eliminates apposed human cervical cancer cells.
Debata PR; Castellanos MR; Fata JE; Baggett S; Rajupet S; Szerszen A; Begum S; Mata A; Murty VV; Opitz LM; Banerjee P
Gynecol Oncol; 2013 Apr; 129(1):145-53. PubMed ID: 23234806
[TBL] [Abstract][Full Text] [Related]
25. Nonsteroidal anti-inflammatory drugs do not interfere with imiquimod treatment for usual type vulvar intraepithelial neoplasia.
Terlou A; Kleinjan A; Beckmann I; Heijmans-Antonissen C; van Seters M; Santegoets LA; van Beurden M; Helmerhorst TJ; Blok LJ
Int J Cancer; 2011 May; 128(10):2463-9. PubMed ID: 20658529
[TBL] [Abstract][Full Text] [Related]
26. In vivo characterization of the inflammatory infiltrate and apoptotic status in imiquimod-treated basal cell carcinoma.
De Giorgi V; Salvini C; Chiarugi A; Paglierani M; Maio V; Nicoletti P; Santucci M; Carli P; Massi D
Int J Dermatol; 2009 Mar; 48(3):312-21. PubMed ID: 19261026
[TBL] [Abstract][Full Text] [Related]
27. Imiquimod-loaded nanocapsules improve cytotoxicity in cervical cancer cell line.
Frank LA; Gazzi RP; de Andrade Mello P; Buffon A; Pohlmann AR; Guterres SS
Eur J Pharm Biopharm; 2019 Mar; 136():9-17. PubMed ID: 30630060
[TBL] [Abstract][Full Text] [Related]
28. Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells.
Lee KH; Yim EK; Kim CJ; Namkoong SE; Um SJ; Park JS
Gynecol Oncol; 2005 Jul; 98(1):45-53. PubMed ID: 15907983
[TBL] [Abstract][Full Text] [Related]
29. p16ink4a expression decreases during imiquimod treatment of anal intraepithelial neoplasia in human immunodeficiency virus-infected men and correlates with the decline of lesional high-risk human papillomavirus DNA load.
Kreuter A; Wieland U; Gambichler T; Altmeyer P; Pfister H; Tenner-Racz K; Racz P; Potthoff A; Brockmeyer NH;
Br J Dermatol; 2007 Sep; 157(3):523-30. PubMed ID: 17573882
[TBL] [Abstract][Full Text] [Related]
30. Imiquimod does not affect shedding of viable chlamydiae in a murine model of Chlamydia trachomatis genital tract infection.
Ramsey KH; Shaba N; Cohoon KP; Ault KA
Infect Dis Obstet Gynecol; 2003; 11(2):81-7. PubMed ID: 14627213
[TBL] [Abstract][Full Text] [Related]
31. [Differential expression of miR-21, miR-126, miR-143, miR-373 in normal cervical tissue, cervical cancer tissue and Hela cell].
Liu L; Wang YL; Wang JF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 43(4):536-9. PubMed ID: 22997891
[TBL] [Abstract][Full Text] [Related]
32. Naringin inhibits growth and induces apoptosis by a mechanism dependent on reduced activation of NF‑κB/COX‑2‑caspase-1 pathway in HeLa cervical cancer cells.
Zeng L; Zhen Y; Chen Y; Zou L; Zhang Y; Hu F; Feng J; Shen J; Wei B
Int J Oncol; 2014 Nov; 45(5):1929-36. PubMed ID: 25174821
[TBL] [Abstract][Full Text] [Related]
33. Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression.
Song Y; Zhang C
Cancer Chemother Pharmacol; 2009 Mar; 63(4):605-13. PubMed ID: 18521605
[TBL] [Abstract][Full Text] [Related]
34. Cell growth inhibition and gene expression regulation by (-)-epigallocatechin-3-gallate in human cervical cancer cells.
Qiao Y; Cao J; Xie L; Shi X
Arch Pharm Res; 2009 Sep; 32(9):1309-15. PubMed ID: 19784588
[TBL] [Abstract][Full Text] [Related]
35. Altered expression of Erg and Ets-2 transcription factors is associated with genetic changes at 21q22.2-22.3 in immortal and cervical carcinoma cell lines.
Simpson S; Woodworth CD; DiPaolo JA
Oncogene; 1997 May; 14(18):2149-57. PubMed ID: 9174050
[TBL] [Abstract][Full Text] [Related]
36. Toll-like receptor 7 stimulation by imiquimod induces macrophage autophagy and inflammation in atherosclerotic plaques.
De Meyer I; Martinet W; Schrijvers DM; Timmermans JP; Bult H; De Meyer GR
Basic Res Cardiol; 2012 May; 107(3):269. PubMed ID: 22543675
[TBL] [Abstract][Full Text] [Related]
37. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
38. Imiquimod treatment of anal intraepithelial neoplasia in HIV-positive men.
Wieland U; Brockmeyer NH; Weissenborn SJ; Hochdorfer B; Stücker M; Swoboda J; Altmeyer P; Pfister H; Kreuter A
Arch Dermatol; 2006 Nov; 142(11):1438-44. PubMed ID: 17116834
[TBL] [Abstract][Full Text] [Related]
39. Anti-HPV Nanoemulsified-Imiquimod: A New and Potent Formulation to Treat Cervical Cancer.
Frank LA; Gazzi RP; Mello PA; Chaves P; Peña F; Beck RCR; Buffon A; Pohlmann AR; Guterres SS
AAPS PharmSciTech; 2020 Jan; 21(2):54. PubMed ID: 31907712
[TBL] [Abstract][Full Text] [Related]
40. Nevirapine induces growth arrest and premature senescence in human cervical carcinoma cells.
Stefanidis K; Loutradis D; Vassiliou LV; Anastasiadou V; Kiapekou E; Nikas V; Patris G; Vlachos G; Rodolakis A; Antsaklis A
Gynecol Oncol; 2008 Nov; 111(2):344-9. PubMed ID: 18822454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
